Angle Health Announces $200M Series C at $2.7B Valuation Led by Vitruvian

Angle Health announced a $200 million Series C at a $2.7 billion valuation led by Vitruvian Partners. The Y Combinator alum said participation included Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator. It operates an AI-powered platform for level-funded health plans for small businesses.